PMSC-ATORVASTATIN

Pharmascience Inc🇨🇦 Health Canada

Approval Id: f6bcbe30c0ad2bde
Drug Approval Canada Name: PMSC-ATORVASTATIN
Product Name: PMSC-ATORVASTATIN
Status: Marketed
Status Date: 2022-03-18
Original Market Date: 2022-03-18
Din: 02507242
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:06.08
Atc Original: C10AA05 ATORVASTATIN
Atc Name: c 10 aa 05
Aig Number: 0133055002
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

ATORVASTATIN (ATORVASTATIN CALCIUM)

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f6bcbe30c0ad2bde

Type

Standard